Denied

No. 12-514

Mylan Pharmaceuticals Inc., et al. v. Eurand, Inc., nka Aptalis Pharmatech, Inc., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of January 11, 2013.

Reply of petitioners Mylan Pharmaceuticals Inc., et al. filed.

Brief of respondents Eurand, Inc., nka Aptalis Pharmatech, Inc., et al. in opposition filed.

Brief amicus curiae of Generic Pharmaceutical Association filed.

Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the respondents.

Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for Par Pharmaceuticals.

Consent to the filing of amicus curiae briefs received from either party or of neither party, received from counsel for petitioners.

Order extending time to file response to petition to and including December 11, 2012.

Petition for a writ of certiorari filed. (Response due November 26, 2012)

Parties

Mylan Pharmaceuticals Inc., et al., Petitioner, represented by James H. Wallace Jr.

Eurand, Inc., nka Aptalis Pharmatech, Inc., et al., Respondent, represented by Jonathan Singer

Amici Curiae

Generic Pharmaceutical Association, Amicus Curiae, represented by Robert L. Byer

 
Last updated: February 16, 2016